Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo

Multidrug resistance (MDR) is a major impediment to cancer treatment. A promising strategy for treating MDR is the joint delivery of combined anticancer agents to tumor cells in a single nanocarrier. Here, for the first time, Resveratrol (Res) was co-encapsulated with paclitaxel (PTX) in a PEGylated...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jie, Guo, Fangqin, Xu, Haiyan, Liang, Wei, Wang, Chen, Yang, Xian-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780086/
https://www.ncbi.nlm.nih.gov/pubmed/26947928
http://dx.doi.org/10.1038/srep22390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780086/
https://www.ncbi.nlm.nih.gov/pubmed/26947928
http://dx.doi.org/10.1038/srep22390

Ejemplares similares